GE HealthCare Technologies Net Profit Margin 2020-2025 | GEHC
Current and historical net profit margin for GE HealthCare Technologies (GEHC) from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. GE HealthCare Technologies net profit margin for the three months ending March 31, 2025 was .
| GE HealthCare Technologies Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $19.80B | $2.18B | 11.03% |
| 2024-12-31 | $19.67B | $1.99B | 10.13% |
| 2024-09-30 | $19.56B | $1.68B | 8.56% |
| 2024-06-30 | $19.52B | $1.58B | 8.10% |
| 2024-03-31 | $19.50B | $1.57B | 8.05% |
| 2023-12-31 | $19.55B | $1.39B | 7.08% |
| 2023-09-30 | $19.28B | $1.54B | 7.97% |
| 2023-06-30 | $19.04B | $1.65B | 8.66% |
| 2023-03-31 | $18.71B | $1.72B | 9.17% |
| 2022-12-31 | $18.34B | $1.92B | 10.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.575B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.781B | 27.87 |
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.17 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |